Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-12-31

Clinical Trial Update: Vesical Imaging-Reporting and Data System (VI-RADS) Followed by Photodynamic Trans-urethral Resection of Bladder Tumours (PDD-TURBT) to Avoid Secondary Resections (Re-TURBT) in Non-Muscle Invasive Bladder Cancers (NMIBCs) [Phase 4]

View source ↗

Summary

This Phase 4 trial is assessing whether VI-RADS imaging followed by photodynamic TURBT (PDD-TURBT) can avoid secondary resections in non-muscle-invasive bladder…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Roma La Sapienza | Conditions: Non-muscle-invasive Bladder Cancer, Non-Muscle Invasive Bladder Urothelial Carcinoma | Phase 4 | Status: RECRUITING